aluminum sulfate has been researched along with Recrudescence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tokunaga, Y | 1 |
| Garcia, M; Groshen, SL; Hamid, O; Scotland, R; Sian, S; Solomon, JC; Weber, JS; Ye, W | 1 |
| Praveen, BV; Sankaranarayanan, A; Vaidyanathan, S | 1 |
2 trial(s) available for aluminum sulfate and Recrudescence
| Article | Year |
|---|---|
Alum with interleukin-12 augments immunity to a melanoma peptide vaccine: correlation with time to relapse in patients with resected high-risk disease.
Topics: Aged; Alum Compounds; Antineoplastic Agents; Cancer Vaccines; Female; Humans; Interleukin-12; Male; Melanoma; Middle Aged; Recurrence; Skin Neoplasms; Time Factors; Treatment Outcome; Vaccines, Subunit | 2007 |
A comparative study of intravesical instillation of 15(s) 15 Me alpha and alum in the management of persistent hematuria of vesical origin.
Topics: Administration, Intravesical; Adult; Aged; Alum Compounds; Dinoprost; Female; Hematuria; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Urinary Bladder Diseases | 1992 |
1 other study(ies) available for aluminum sulfate and Recrudescence
| Article | Year |
|---|---|
Clinical utility of sclerotherapy with a new agent for treatment of rectal prolapse in patients with risks.
Topics: Aged; Aged, 80 and over; Alum Compounds; Drug Combinations; Female; Humans; Injections; Rectal Prolapse; Recurrence; Retrospective Studies; Sclerosing Solutions; Sclerotherapy; Tannins; Treatment Outcome | 2014 |